GB9707251D0 - Novel method and compounds - Google Patents

Novel method and compounds

Info

Publication number
GB9707251D0
GB9707251D0 GBGB9707251.6A GB9707251A GB9707251D0 GB 9707251 D0 GB9707251 D0 GB 9707251D0 GB 9707251 A GB9707251 A GB 9707251A GB 9707251 D0 GB9707251 D0 GB 9707251D0
Authority
GB
United Kingdom
Prior art keywords
compounds
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9707251.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9707251.6A priority Critical patent/GB9707251D0/en
Publication of GB9707251D0 publication Critical patent/GB9707251D0/en
Priority to PCT/EP1998/002139 priority patent/WO1998045293A1/en
Priority to JP54240998A priority patent/JP2001519798A/en
Priority to CA002286452A priority patent/CA2286452A1/en
Priority to EP98919259A priority patent/EP0973773A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9707251.6A 1997-04-10 1997-04-10 Novel method and compounds Pending GB9707251D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9707251.6A GB9707251D0 (en) 1997-04-10 1997-04-10 Novel method and compounds
PCT/EP1998/002139 WO1998045293A1 (en) 1997-04-10 1998-04-03 Pyrimido-isoquinoline compounds with anticonvulsive action
JP54240998A JP2001519798A (en) 1997-04-10 1998-04-03 Pyrimido-isoquinoline compounds having anticonvulsant action
CA002286452A CA2286452A1 (en) 1997-04-10 1998-04-03 Pyrimido-isoquinoline compounds with anticonvulsive action
EP98919259A EP0973773A1 (en) 1997-04-10 1998-04-03 Pyrimido-isoquinoline compounds with anticonvulsive action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9707251.6A GB9707251D0 (en) 1997-04-10 1997-04-10 Novel method and compounds

Publications (1)

Publication Number Publication Date
GB9707251D0 true GB9707251D0 (en) 1997-05-28

Family

ID=10810566

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9707251.6A Pending GB9707251D0 (en) 1997-04-10 1997-04-10 Novel method and compounds

Country Status (5)

Country Link
EP (1) EP0973773A1 (en)
JP (1) JP2001519798A (en)
CA (1) CA2286452A1 (en)
GB (1) GB9707251D0 (en)
WO (1) WO1998045293A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007092A2 (en) * 2003-07-08 2005-01-27 Smithkline Beecham Corporation Novel chemical compounds
EP2619203A4 (en) 2010-09-20 2014-04-16 Glaxo Group Ltd Tricyclic compounds, preparation methods, and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237429A (en) * 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
FI895463A0 (en) * 1988-11-19 1989-11-16 Hoechst Ag PHARMACEUTICAL FORM
US5114944A (en) * 1991-04-12 1992-05-19 A. H. Robins Company Incorporated 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects

Also Published As

Publication number Publication date
WO1998045293A1 (en) 1998-10-15
CA2286452A1 (en) 1998-10-15
EP0973773A1 (en) 2000-01-26
JP2001519798A (en) 2001-10-23

Similar Documents

Publication Publication Date Title
EP1037635A4 (en) Compounds and methods
GB9828640D0 (en) Novel method and compounds
HUP0000911A3 (en) Refuse-treatment method
GB2345063B (en) Method
GB9721603D0 (en) Method
GB9706282D0 (en) Method
PL334701A1 (en) Novel method
GB9700320D0 (en) Method
GB9707744D0 (en) Method
ZA9810471B (en) New method
GB9717652D0 (en) Method
PL341657A1 (en) Deparaffining method
GB9707251D0 (en) Novel method and compounds
GB9725462D0 (en) Novel method
GB9709811D0 (en) Method
GB9827521D0 (en) Novel method and compounds
GB9821974D0 (en) Novel method and compounds
GB9705683D0 (en) Novel method
GB9715269D0 (en) Novel method
GB9715266D0 (en) Novel method
GB9715150D0 (en) Novel method
GB9700940D0 (en) Novel method
GB9718832D0 (en) Novel compounds and process
GB9713963D0 (en) Method
GB9723920D0 (en) Method